The effect of 1,1-(2,7-dimorphocino-6-phenyl-4-pteridinyl-imino) di-2-propanol (RE102), a dipyridamol derivative, upon the general and cardiac haemodynamics of the intact dog.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002245:Carbon Dioxide / Q000378:metabolism; D002302:Cardiac Output / Q000187:drug effects*; D003331:Coronary Vessels / Q000032:analysis / Q000187:drug effects*; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000032:analysis; D005263:Femoral Artery; D005947:Glucose / Q000032:analysis; D006339:Heart Rate / Q000187:drug effects; D007773:Lactates / Q000032:analysis; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D011621:Pteridines / Q000494:pharmacology*; D011651:Pulmonary Artery; D012039:Regional Blood Flow; D014665:Vasodilator Agents
D005230:Fatty Acids, Nonesterified; D007773:Lactates; D011621:Pteridines; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D005947:Glucose